Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole Hcl + Anlotinib in Advanced Intrahepatic Cholangiocarcinoma
NCT03940378Phase 3Unknown
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Feb 2019
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levamisole in intrahepatic cholangiocarcinoma (ICC), sponsored by The First Affiliated Hospital of Zhengzhou University. Status: unknown.
02
Drugs
levamisole
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT03940378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03940378.